On February 6, 2020 Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, reported that company management will participate in two upcoming conferences (Press release, Xencor, FEB 6, 2020, View Source [SID1234553958]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Healthcare Talks Forum | Oncology Day
Date: Thursday, February 13, 2020
Location: New York
Presentation Time: 9:00 a.m. EST
9th Annual SVB Leerink Global Healthcare Conference
Date: Wednesday, February 26, 2020
Location: New York
Presentation Time: 11:00 a.m. EST
Live webcasts of these presentations will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. A replay of the events will be posted on the Xencor website approximately one hour after the live events and will be available for 30 days following the presentations.